RxDoctor Payments Data

Sarah Parker, NP

Family · Demorest, GANPI 1063863645

Payments from drug & device makers

$1,931in general payments, 2019–2025

Across 100 payments — averaging $19.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$387
  • AbbVie$264
  • Daiichi Sankyo Inc.$158
  • GSK$150
  • Lilly USA, LLC$133
  • Corcept Therapeutics$119
  • plus $721 from 13 others

What the payments were for

  • Food & beverage$1,931100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,931 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$714
Medicare patients
29
Services billed
51

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide44$51,176
FarxigaDapagliflozin Propanediol27$25,501
EliquisApixaban37$25,368
MounjaroTirzepatide13$23,427
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$22,081
OzempicSemaglutide20$15,963
LinzessLinaclotide15$11,717
Lantus SolostarInsulin Glargine,hum.Rec.Anlog47$5,428
MyrbetriqMirabegron11$5,413
Aripiprazole12$2,554
Dexlansoprazole DrDexlansoprazole15$2,452
Sucralfate28$2,419
Novolog FlexpenInsulin Aspart18$2,267
Mometasone Furoate19$1,593
Albuterol Sulfate HfaAlbuterol Sulfate94$1,506

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$133$74,60357 claims
AstraZenecaFarxiga$110$25,50127 claims
PfizerEliquis$56$25,36837 claims
GSKTrelegy Ellipta$150$22,08134 claims
Novo NordiskOzempic$20$15,96320 claims
AbbVieLinzess$264$11,71715 claims
Astellas Pharma US IncMyrbetriq$33$5,41311 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$14$1,304139 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,258 family providers in Georgia.

Other family in Demorest

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →